# Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years

> **NCT06993636** · — · RECRUITING · sponsor: **Children's Hospital of Fudan University** · enrollment: 60 (estimated)

## Conditions studied

- Kawasaki Disease
- Coronary Artery Aneurysm
- Rivaroxaban
- Anticoagulant Drugs
- Pharmacokinetics and Pharmacodynamics

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06993636
- **Lead sponsor:** Children's Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06993636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06993636, "Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT06993636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*